Switch to:
More From Other Websites
Rumored Danone Medical Food Sale To Hospira Would End Ambition Jul 28 2014
Pfizer's need for deal looms larger with earnings report Jul 28 2014
Pfizer's need for deal looms larger with earnings report Jul 28 2014
Week Ahead: Traders Eye Fed, GDP, Jobs, Earns, IPOs Jul 27 2014
What to Watch in the Week Ahead and on Monday, July 28 Jul 25 2014
Puma’s Auerbach Gained on Pfizer’s Breast Drug Retreat Jul 25 2014
3 Stocks Reiterated As A Buy: PFE, OXY, ORCL Jul 25 2014
AstraZeneca results to get lift from bid foe Pfizer Jul 25 2014
The Zacks Analyst Blog Highlights: Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and... Jul 25 2014
Obama Goes On The Attack Against Companies Doing Inversions To Move To Countries Where They Pay Less... Jul 25 2014
Premier Biomedical Gears Up for Two Important Clinical Trials Jul 25 2014
Pfizer Ltd’s Profit from operations before other income, finance cost and tax for the Quarter... Jul 25 2014
Botox Maker’s Bosses Put Money Where Their Mouths Are Jul 24 2014
Pfizer Needs to Do a Deal, Analyst Says Jul 24 2014
Michigan governor's campaign met with ambivalence Jul 24 2014
Did Pfizer Make A Horrible Business Deal? Jul 24 2014
[video] Caterpillar CEO sees mining 'green shoots' Jul 24 2014
[video] Eli Lilly looking for smaller acquisitions: CEO Jul 24 2014
[video] Results hurt by patent expirations: Eli Lilly CEO Jul 24 2014


Add Notes, Comments or Ask Questions

User Comments

SEENSCO
ReplySEENSCO - 1 month ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide